Delivery Order SPE2DB20D1100-SPE2DB23FD2D5

Award Date 8/22/23
Potential Completion Date 8/23/23
Potential Value $13K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $7,100 to Amerisourcebergen Drug Corporation for the supply of 4561860956 Pulmozyme 1 MG/ML ampules. The delivery order, issued under an unspecified governmentwide acquisition contract, calls for Amerisourcebergen to deliver 2.5mL ampules of the respiratory drug Pulmozyme to a location in Conshohocken, Pennsylvania by August 21, 2023. No subcontractors or set-aside...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $30,000 to Amerisourcebergen Drug Corporation to supply Pulmozyme 1 mg/ml ampules. The delivery order was issued under an existing Amerisourcebergen contract vehicle and calls for the contractor to deliver 2.5ml ampules of the respiratory drug to a location in Conshohocken, Pennsylvania, with performance to be completed between September 8-11, 2023. Amerisourcebergen Corporation will perform as the...
The Defense Logistics Agency awarded a $6,394.32 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561851817 Pulmozyme 1 MG/ML ampules. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the medication to a location in Conshohocken, Pennsylvania by August 18, 2023 in fulfillment of this order issued under an indefinite-delivery/indefinite-quantity contract vehicle. No subcontractors or set aside designations were...
The Defense Logistics Agency awarded a $19,316 delivery order to Amerisourcebergen Drug Corporation for 4561806979 Pulmozyme 1 MG/ML Ampul 2.5ML. The firm fixed price order is for delivery of the specified pharmaceutical product to a location in Conshohocken, Pennsylvania, with performance required from August 14 to August 15, 2023. As a top supplier of medical materiel to the Department of Defense, Amerisourcebergen will fulfill this order from the Defense Logistics Agency in support of the...
The Defense Logistics Agency awarded a $7,751.32 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561926624 Pulmozyme 1 mg/ml ampul 2.5ml. The contract has a period of performance from August 24, 2023 through August 25, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency leverages contracts such as this to efficiently procure...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at twelve thousand five hundred seventeen dollars and fifty-nine cents ($12,517.59) to Amerisourcebergen Drug Corporation for 4561315770 Pulmozyme 1 mg/ml ampul 2.5ml. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania by June 23, 2023. No additional details were provided regarding the original solicitation requirements. Amerisourcebergen Corporation is the parent company of...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $17,823.84 to Amerisourcebergen Drug Corporation for the provision of 4561667293 units of Pulmozyme 1 mg/ml ampules in 2.5 ml quantities. Performance will take place in Conshohocken, Pennsylvania. The delivery order was issued against an existing Amerisourcebergen Corporation indefinite-delivery/indefinite-quantity contract vehicle and runs from August 1, 2023 through August 2, 2023. No...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $15,322.35 to Amerisourcebergen Drug Corporation for 4561654005 Pulmozyme 1 MG/ML Ampul 2.5ML. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 1, 2023 under the terms of the order. No set aside designation or subcontracting details were provided. The Defense Logistics Agency functions include procuring...
The Defense Logistics Agency awarded a $7,127.11 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561985367 Pulmozyme 1 mg/ml ampul 2.5ml. Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 30, 2023 in support of the Defense Logistics Agency's medical supply chain programs. As the prime contractor, Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation and will...
The Defense Logistics Agency awarded a $14,683.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561948828 Pulmozyme 1 mg/ml ampul 2.5ml. The contract has a period of performance from August 25, 2023 through August 28, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency leverages contracts such as Federal Supply Schedule 65IIa...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB23FD2D5
    Delivery Order

The Defense Logistics Agency awarded a $13,157.79 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561904221 Pulmozyme 1 MG/ML ampules. As the prime contractor, Amerisourcebergen will deliver 2.5mL ampules of the respiratory medication to the specified location in Conshohocken, Pennsylvania by August 23, 2023. The order was placed under an existing DLA contract vehicle and supports the Agency's mission to provide medical supplies and pharmaceuticals to military treatment facilities worldwide. No set aside designation or subcontractors were indicated.

Generated 12/23/23, 10:18 PM